All companies
Visit website
SciTech Development, L.L.C.
OperatingSCITECH DEVELOPMENT L.L.C.
Healthcare · Biotech · Founded 2000
Advancing cancer treatment through safer drug delivery
Post-money valuation ⓘ
$64.0M
As of Jul 2022 · from SciTech Development, L.L.C. · pre-money + amount raised, not a traded price
Total raised
$84,118
Across 1 round since 2022
Latest share price
$2.75
SciTech Development, L.L.C. offering price
Financials
FY2019–FY2025 · from SEC filings · hover any figure for its source$0
−$276K
2019
$0
−$358K
2020
$0
−$317K
2021
$0
−$767K
2022
$0
−$1.7M
2023
$0
−$4.6M
2024
$0
−$7.1M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Income statement
Revenue
$0
$0
$0
$0
$0
$0
$0
Cost of goods sold
$0
$352,742
$312,831
$732,503
$1,762,307
$1,022,166
$3,907,693
Net income
-$276,167
-$357,642
-$316,648
-$767,176
-$1,713,567
-$4,588,546
-$7,137,960
Taxes paid
$0
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$370,223
$133,834
$37,225
$494,776
$1,654,291
$2,148,456
$922,758
Accounts receivable
$0
$0
$0
$0
$0
$0
$0
Total assets
$493,530
$327,348
$295,356
$900,198
$2,346,957
$2,175,920
$962,094
Short-term debt
$0
$0
$192,650
$0
$1,723,750
$7,879,660
$0
Long-term debt
$1,360,186
$810,332
$750,332
$1,950,732
$0
$0
$3,916
Total liabilities
$1,360,186
$810,332
$942,982
$1,950,732
$1,723,750
$7,879,660
$3,916
Other
Headcount
—
3
3
3
—
10
3
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$64.0M
post-money
SciTech Development, L.L.C.
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $84.1K / $5MInvestors 100Post-money $64M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 4 of 5 annual reports (FY2021–FY2025)
100 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 15 filings on EDGARSource: ManualCIK 0001682585Share price $2.75
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.